Concepedia

Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint Inhibitor

Mark Doherty, Kevin Jao, Frances A. Shepherd, Lili‐Naz Hazrati, Natasha B. Leighl

Journal of Thoracic Oncology · 2015 · 38 citations · 4 references

DOIFull text

Open access

Concepts

References

4

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Jedd D. Wolchok, Axel Hoos, Steven O’Day et al. · Clinical Cancer Research · 2009 · 3.2K citations

, , +17

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

Naiyer A. Rizvi, Julien Mazières, David Planchard et al. · The Lancet Oncology · 2015 · 1.4K citations

, , +17

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

Kim Margolin, Marc S. Ernstoff, Omid Hamid et al. · The Lancet Oncology · 2012 · 1.1K citations

, , +12

The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases.

Yvonne M. Saenger, Jedd D. Wolchok · PubMed · 2008 · 166 citations · Full text

, , +17